{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:33:26Z","timestamp":1761863606291},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0161376","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T17:47:48Z","timestamp":1471542468000},"page":"e0161376","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria"],"prefix":"10.1371","volume":"11","author":[{"given":"Emanuel","family":"Zitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanze","family":"Pscheidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Concin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Kramar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Lhotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,8,18]]},"reference":[{"key":"ref1","unstructured":"Dialysis Austrian and Registry Transplantation (OEDTR), Annual Report 2014, Austrian Society of Nephrology 2014. Available from: www.nephro.at<\/ext-link>."},{"key":"ref2","unstructured":"United States Renal Data System, 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014 2014. Available from: www.usrds.org<\/ext-link>."},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/archinternmed.2008.605","article-title":"Risk factors for end-stage renal disease: 25-year follow-up","volume":"169","author":"CY Hsu","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2796.2009.02197.x","article-title":"Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland","volume":"267","author":"M Kastarinen","year":"2010","journal-title":"J Intern Med"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/01.HYP.0000069699.92349.8C","article-title":"Blood pressure predicts risk of developing end-stage renal disease in men and women","volume":"41","author":"M Tozawa","year":"2003","journal-title":"Hypertension"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2215\/CJN.02180311","article-title":"Metabolic syndrome and kidney disease: a systematic review and meta-analysis","volume":"6","author":"G Thomas","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"21","key":"ref7","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/2013.jamainternmed.85","article-title":"Body mass index in 1.2 million adolescents and risk for end-stage renal disease","volume":"172","author":"A Vivante","year":"2012","journal-title":"Arch Intern Med"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.ajkd.2014.06.019","article-title":"Predictors in adolescence of ESRD in middle-aged men","volume":"64","author":"PO Sundin","year":"2014","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ki.2011.157","article-title":"Smoking is a risk factor in the progression to kidney failure","volume":"80","author":"SI Hallan","year":"2011","journal-title":"Kidney international"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"e0135052","DOI":"10.1371\/journal.pone.0135052","article-title":"Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up","volume":"10","author":"C Pscheidt","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0195-668X(03)00170-2","article-title":"Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring & Promotion Programme","volume":"24","author":"H Ulmer","year":"2003","journal-title":"Eur Heart J"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10654-009-9312-4","article-title":"Body mass index and mortality: results of a cohort of 184,697 adults in Austria","volume":"24","author":"J Klenk","year":"2009","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/ndt\/gfg184","article-title":"Regional variability in the incidence of end-stage renal disease: an epidemiological approach","volume":"18","author":"F Wimmer","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","unstructured":"World Health Organisation BMI classification [21.06.2014]. Available from: http:\/\/apps.who.int\/bmi\/index.jsp?introPage=intro_3.html<\/ext-link>."},{"issue":"Suppl 1","key":"ref15","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.2337\/dc12-s064","article-title":"Diagnosis and classification of diabetes mellitus","volume":"35","author":"A American Diabetes","year":"2012","journal-title":"Diabetes Care"},{"issue":"25","key":"ref16","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"ref17","article-title":"Diabetes-related end-stage renal disease in Austria 1965\u20132013","author":"FC Prischl","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"16","key":"ref18","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"EW Gregg","year":"2014","journal-title":"The New England journal of medicine"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ki.2014.120","article-title":"Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease","volume":"86","author":"EM Spithoven","year":"2014","journal-title":"Kidney international"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"e1001750","DOI":"10.1371\/journal.pmed.1001750","article-title":"Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"11","author":"M Hecking","year":"2014","journal-title":"PLoS Med"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0272-6386(95)90119-1","article-title":"The impact of gender on the progression of chronic renal disease","volume":"25","author":"SR Silbiger","year":"1995","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1681\/ASN.V112319","article-title":"Effect of gender on the progression of nondiabetic renal disease: a meta-analysis","volume":"11","author":"J Neugarten","year":"2000","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.ki.5000058","article-title":"The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age","volume":"69","author":"BO Eriksen","year":"2006","journal-title":"Kidney international"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199601043340103","article-title":"Blood pressure and end-stage renal disease in men","volume":"334","author":"MJ Klag","year":"1996","journal-title":"The New England journal of medicine"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archinte.165.8.923","article-title":"Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease","volume":"165","author":"CY Hsu","year":"2005","journal-title":"Arch Intern Med"},{"issue":"4 Suppl 2","key":"ref26","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1053\/j.ajkd.2012.12.016","article-title":"Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP)","volume":"61","author":"TI Chang","year":"2013","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"ref27","article-title":"Mid-Adulthood Risk Factor Profiles for CKD","author":"GM McMahon","year":"2014","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2215\/CJN.09320913","article-title":"Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study","volume":"9","author":"M Rahman","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","article-title":"Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study","volume":"58","author":"P Muntner","year":"2000","journal-title":"Kidney international"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMsa1407211","article-title":"Smoking and mortality\u2014beyond established causes","volume":"372","author":"BD Carter","year":"2015","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10157-012-0706-3","article-title":"Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience","volume":"17","author":"A Ozkok","year":"2013","journal-title":"Clinical and experimental nephrology"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1681\/ASN.2005060638","article-title":"Obesity and risk for chronic renal failure","volume":"17","author":"E Ejerblad","year":"2006","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1523-1755.2004.00582.x","article-title":"Body mass index and the risk of development of end-stage renal disease in a screened cohort","volume":"65","author":"K Iseki","year":"2004","journal-title":"Kidney international"},{"key":"ref34","article-title":"Obesity, metabolic health, and the risk of end-stage renal disease","author":"B Panwar","year":"2014","journal-title":"Kidney international"},{"issue":"7258","key":"ref35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"IM Stratton","year":"2000","journal-title":"BMJ"},{"issue":"7258","key":"ref36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"AI Adler","year":"2000","journal-title":"BMJ"},{"issue":"24","key":"ref37","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2 diabetes mellitus\/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"S Bangalore","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"BM Brenner","year":"2001","journal-title":"The New England journal of medicine"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"HH Parving","year":"2001","journal-title":"The New England journal of medicine"},{"issue":"19","key":"ref40","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"P Ruggenenti","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/dc08-0137","article-title":"Explaining the decline in early mortality in men and women with type 2 diabetes: a population-based cohort study","volume":"31","author":"J Charlton","year":"2008","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"ref42","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","author":"A American Diabetes","year":"2013","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"ref43","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/ndt\/gfv100","article-title":"Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL\/min)","volume":"30","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"P Gaede","year":"2003","journal-title":"The New England journal of medicine"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"P Gaede","year":"2008","journal-title":"The New England journal of medicine"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1515\/CCLM.2010.031","article-title":"Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer\u2014a narrative review","volume":"48","author":"G Targher","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"ref47","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1373\/clinchem.2004.045872","article-title":"Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study","volume":"51","author":"DH Lee","year":"2005","journal-title":"Clin Chem"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2369-14-177","article-title":"Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population","volume":"14","author":"G Nagel","year":"2013","journal-title":"BMC Nephrol"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1681\/ASN.2013111184","article-title":"Predictors of autosomal dominant polycystic kidney disease progression","volume":"25","author":"RW Schrier","year":"2014","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"24","key":"ref50","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"RW Schrier","year":"2014","journal-title":"The New England journal of medicine"},{"issue":"24","key":"ref51","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","author":"VE Torres","year":"2014","journal-title":"The New England journal of medicine"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"E Cornec-Le Gall","year":"2013","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1310753","article-title":"Stenting and medical therapy for atherosclerotic renal-artery stenosis","volume":"370","author":"CJ Cooper","year":"2014","journal-title":"The New England journal of medicine"},{"issue":"9136","key":"ref54","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(98)04433-X","article-title":"Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy","volume":"352","author":"P Ruggenenti","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"O Gross","year":"2012","journal-title":"Kidney international"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0161376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T05:49:45Z","timestamp":1657086585000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0161376"}},"subtitle":[],"editor":[{"given":"Shiro","family":"Maeda","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,18]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0161376","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,18]]}}}